BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8038351)

  • 1. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.
    Hurlimann S; Abbühl B; Inauen W; Halter F
    Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole.
    Prewett EJ; Hudson M; Nwokolo CU; Sawyerr AM; Pounder RE
    Gastroenterology; 1991 Apr; 100(4):873-7. PubMed ID: 2001826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged inhibition of acid secretion causes hypergastrinaemia without altering pH inhibition of gastrin release in humans.
    Karnes WE; Berlin RG; Maxwell V; Sytnik B; Root JK; Walsh JH
    Aliment Pharmacol Ther; 1990 Oct; 4(5):443-56. PubMed ID: 2129633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.
    Williams MP; Sercombe J; Hamilton MI; Pounder RE
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1079-89. PubMed ID: 9845397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
    Decktor DL; Pendleton RG; Kellner AT; Davis MA
    J Pharmacol Exp Ther; 1989 Apr; 249(1):1-5. PubMed ID: 2565384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?
    Merki HS; Wilder-Smith CH
    Gastroenterology; 1994 Jan; 106(1):60-4. PubMed ID: 8276209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine.
    Merki HS; Halter F; Wilder-Smith CH
    Gastroenterology; 1993 Sep; 105(3):748-54. PubMed ID: 8103027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion.
    Blum RA; Shi H; Karol MD; Greski-Rose PA; Hunt RH
    Clin Ther; 1997; 19(5):1013-23. PubMed ID: 9385488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-four-hour intragastric acidity: 300 mg ranitidine b.d., 20 mg omeprazole o.m., 40 mg omeprazole o.m. vs. placebo.
    Houben GM; Hooi J; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 1995 Dec; 9(6):649-54. PubMed ID: 8824652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of single intravenously administered doses of omeprazole and ranitidine on intragastric pH and plasma gastrin concentration in nonfed ponies.
    Baker SJ; Gerring EL
    Am J Vet Res; 1993 Dec; 54(12):2068-74. PubMed ID: 8116940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH.
    Khoury RM; Katz PO; Hammod R; Castell DO
    Aliment Pharmacol Ther; 1999 May; 13(5):675-8. PubMed ID: 10233192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of omeprazole and ranitidine on plasma gastrin concentration and stomach gastrin content in rats.
    Seensalu R; Girma K; Romell B; Nilsson G
    Ups J Med Sci; 1992; 97(2):157-67. PubMed ID: 1471315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance during 5 months of dosing with ranitidine, 150 mg nightly: a placebo-controlled, double-blind study.
    Nwokolo CU; Prewett EJ; Sawyerr AM; Hudson M; Lim S; Pounder RE
    Gastroenterology; 1991 Oct; 101(4):948-53. PubMed ID: 1889719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis.
    Lind T; Cederberg C; Idström JP; Lönroth H; Olbe L; Lundell L
    Scand J Gastroenterol; 1991 Jun; 26(6):620-6. PubMed ID: 1862300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian differences in pharmacological blockade of meal-stimulated gastric acid secretion.
    Sanders SW; Moore JG; Day GM; Tolman KG
    Aliment Pharmacol Ther; 1992 Apr; 6(2):187-93. PubMed ID: 1600040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.
    Kiilerich S; Rannem T; Elsborg L
    Digestion; 1995; 56(1):25-30. PubMed ID: 7895928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ranitidine 150 mg four times a day on 24-hour intragastric acidity and 24-hour plasma gastrin concentration.
    Fraser AG; Sawyerr AM; Hudson M; Smith M; Pounder RE
    Dig Dis Sci; 1994 Jan; 39(1):91-6. PubMed ID: 8281874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
    Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
    J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.